Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

6.430 +0.020 (+0.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 343,862
Open 6.400
Bid (Size) 6.470 (100)
Ask (Size) 6.490 (600)
Prev. Close 6.410
Today's Range 6.316 - 6.560
52wk Range 5.540 - 22.25
Shares Outstanding 17,618,607
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
News headline image
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
-48.2%
-48.2%
1 Month
-5.2%
-5.2%
3 Month
-46.2%
-46.2%
6 Month
-67.2%
-67.2%
1 Year
-23.5%
-23.5%

More News

Read More
OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook ↗
Via Chartmill
News headline image
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Whetstone Capital Exits GitLab as Enterprises Rethink AI-Driven Software Development Tools ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund Added 415,000 Shares of a Software Stock Down 26% This Past Year ↗
Via The Motley Fool
News headline image
This Fund Just Bought $6 Million in Plug Power Stock — Is a Turnaround in Sight? ↗
Via The Motley Fool
Topics Economy Regulatory Compliance
News headline image
Whetstone Sells All Freshworks Shares ↗
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
News headline image
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
OptimizeRx Corp (NASDAQ:OPRX) Shows High-Growth Momentum with Strong Technical Breakout ↗
Via Chartmill
News headline image
OptimizeRx Corp (NASDAQ:OPRX) Delivers Strong Q3 Beat and Raises Guidance ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OPTIMIZERX CORP (NASDAQ:OPRX) Shows Strong Momentum with Minervini Trend Template and High Growth Fundamentals ↗
Via Chartmill
News headline image
UnitedHealth Group Under Siege: DOJ Probes and Cyberattack Aftermath Shake Healthcare Giant
Via MarketMinute
Topics Economy Lawsuit
News headline image
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
From OptimizeRx Corporation
Via GlobeNewswire

Frequently Asked Questions

Is OptimizeRx Corporation - Common Stock publicly traded?
Yes, OptimizeRx Corporation - Common Stock is publicly traded.
What exchange does OptimizeRx Corporation - Common Stock trade on?
OptimizeRx Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OptimizeRx Corporation - Common Stock?
The ticker symbol for OptimizeRx Corporation - Common Stock is OPRX on the Nasdaq Stock Market
What is the current price of OptimizeRx Corporation - Common Stock?
The current price of OptimizeRx Corporation - Common Stock is 6.430
When was OptimizeRx Corporation - Common Stock last traded?
The last trade of OptimizeRx Corporation - Common Stock was at 04/24/26 04:00 PM ET
What is the market capitalization of OptimizeRx Corporation - Common Stock?
The market capitalization of OptimizeRx Corporation - Common Stock is 113.29M
How many shares of OptimizeRx Corporation - Common Stock are outstanding?
OptimizeRx Corporation - Common Stock has 113M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.